These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1055101)

  • 1. In vitro "education" on autologous human sarcoma generates non-specific killer cells.
    Martin-Chandon MR; Vanky F; Carnaud C; Klein E
    Int J Cancer; 1975 Feb; 15(2):342-50. PubMed ID: 1055101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
    [No Abstract]   [Full Text] [Related]  

  • 3. Disappearance after chemotherapy of blocking serum factors as measured in vitro with lymphocytes cytotoxic to tumor cells.
    Sinkovics JG; Cabiness JR; Shullenberger CC
    Cancer; 1972 Dec; 30(6):1428-37. PubMed ID: 4509102
    [No Abstract]   [Full Text] [Related]  

  • 4. Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma.
    Yu A; Watts H; Jaffe N; Parkman R
    N Engl J Med; 1977 Jul; 297(3):121-7. PubMed ID: 325412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
    Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of in vitro immune response with clinical course of malignant neoplasia in dogs.
    Brodey RS; Fidler IJ; Bech-Nielsen S
    Am J Vet Res; 1975 Jan; 36(1):75-80. PubMed ID: 1054221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating antibodies in human connective tissue malignancy.
    Moore M; Hughes LA
    Br J Cancer Suppl; 1973 Aug; 1():175-84. PubMed ID: 4613373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The host immune response in human osteosarcoma.
    McMaster JH; Ferguson RJ; Weinert CR
    Clin Orthop Relat Res; 1975 Sep; (111):76-82. PubMed ID: 1057466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-associated antigen from the SV40-induced hamster fibrosarcoma, para-7. I. Role in immune complex formation and effector cell blockade.
    Prather SO; Lausch RN
    Int J Cancer; 1976 Dec; 18(6):820-8. PubMed ID: 62726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro generation of cytotoxicity against autologous human tumour biopsy cells.
    Vose BM; Vánky F; Fopp M; Klein E
    Int J Cancer; 1978 May; 21(5):588-93. PubMed ID: 659024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytotoxicity of lymphocytes sensitized by autologous tumor cells in vitro, against autologous lung cancer cell lines].
    Inaba H; Kobayashi S; Okada S; Fujimura S; Nakata T
    Nihon Geka Gakkai Zasshi; 1990 Apr; 91(4):515-23. PubMed ID: 2142996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
    Wilhelm SA; Mukherji B
    J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chondrosarcoma. Immune reactions of a patient to autologous tumor.
    Sinkovics JG; Shirato E; Martin RG; Cabiness JR; White EC
    Cancer; 1971 Apr; 27(4):782-93. PubMed ID: 4929935
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.
    Currie GA; Lejeune F; Fairley GH
    Br Med J; 1971 May; 2(5757):305-10. PubMed ID: 4930209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermia increases the susceptibility of chondro- and osteosarcoma cells to natural killer cell-mediated lysis.
    Kubista B; Trieb K; Blahovec H; Kotz R; Micksche M
    Anticancer Res; 2002; 22(2A):789-92. PubMed ID: 12014651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic and virus studies with human sarcomas.
    Morton DL; Malmgren RA; Hall WT; Schidlovsky G
    Surgery; 1969 Jul; 66(1):152-61. PubMed ID: 4306938
    [No Abstract]   [Full Text] [Related]  

  • 19. Serologic analysis of human tumor antigens. II. Reactivity of sera from eleven osetogenic sarcoma patients against autologous and allogeneic tumor cells.
    Rosenberg SA; Tondreau SC; Shoffner PC; Hyatt C; Brown JM; Thorpe W; Sindelar W
    Surgery; 1979 Aug; 86(2):258-65. PubMed ID: 288177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific anti-tumor responses by cultured immune spleen cells. II. Culture supernatants induce specific anti-tumor cytotoxicity by non-immune lymphoid cells in vitro.
    Nelson K; Pollack SB; Hellström KE
    Int J Cancer; 1975 Aug; 16(2):292-300. PubMed ID: 1150355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.